These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2459295)

  • 61. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
    Townsend AR; Rothbard J; Gotch FM; Bahadur G; Wraith D; McMichael AJ
    Cell; 1986 Mar; 44(6):959-68. PubMed ID: 2420472
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rotavirus-specific cytotoxic T lymphocytes recognize overlapping epitopes in the amino-terminal region of the VP7 glycoprotein.
    Buesa J; Raga JV; Colomina J; de Souza CO; Muñoz C; Gil MT
    Virology; 1999 May; 257(2):424-37. PubMed ID: 10329553
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies.
    Anton LC; Yewdell JW; Bennink JR
    J Immunol; 1997 Mar; 158(6):2535-42. PubMed ID: 9058784
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.
    Endo A; Itamura S; Iinuma H; Funahashi S; Shida H; Koide F; Nerome K; Oya A
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():699-703. PubMed ID: 2005435
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.
    Kutubuddin M; Simons J; Chow M
    J Virol; 1992 Oct; 66(10):5967-74. PubMed ID: 1382144
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation.
    Wraith DC; Askonas BA
    J Gen Virol; 1985 Jun; 66 ( Pt 6)():1327-31. PubMed ID: 3874261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.
    Esquivel F; Yewdell J; Bennink J
    J Exp Med; 1992 Jan; 175(1):163-8. PubMed ID: 1309852
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway.
    Neumeister C; Nanan R; Cornu TI; Lüder CGK; Ter Meulen V; Naim H; Niewiesk S
    J Gen Virol; 2001 Feb; 82(Pt 2):441-447. PubMed ID: 11161284
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Presentation of an influenza nucleoprotein epitope incorporated into the H-2Db signal sequence requires the transporter-associated with antigen presentation.
    Uger RA; Barber BH
    J Immunol; 1997 Jan; 158(2):685-92. PubMed ID: 8992984
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes.
    Eisenlohr LC; Yewdell JW; Bennink JR
    J Exp Med; 1992 Feb; 175(2):481-7. PubMed ID: 1732413
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
    van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
    Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes.
    McMichael AJ; Michie CA; Gotch FM; Smith GL; Moss B
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():719-26. PubMed ID: 3485697
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A monoclonal antibody produced during infection which recognizes an epitope of influenza hemagglutinin only in the context of H-2k MHC class I antigen.
    McLain L; Dimmock NJ
    J Immunol; 1993 Apr; 150(8 Pt 1):3421-6. PubMed ID: 7682240
    [TBL] [Abstract][Full Text] [Related]  

  • 78. On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.
    Braciale TJ; Braciale VL; Winkler M; Stroynowski I; Hood L; Sambrook J; Gething MJ
    J Exp Med; 1987 Sep; 166(3):678-92. PubMed ID: 2442285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.
    Li S; Rodrigues M; Rodriguez D; Rodriguez JR; Esteban M; Palese P; Nussenzweig RS; Zavala F
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5214-8. PubMed ID: 7685119
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
    Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P
    Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.